Sequential chemotherapy and myeloablative allogeneic hematopoietic stem cell transplantation for refractory acute lymphoblastic leukemia
スポンサーリンク
概要
- 論文の詳細を見る
The prognosis of patients receiving allogeneic hematopoietic stem cell transplantation (HSCT) for refractory acute lymphoblastic leukemia (ALL) is very poor. To improve survival rates, we attempted to intensify the conditioning regimen with daunorubicin, vincristine, prednisolone, medium-dose etoposide, cyclophosphamide, and total body irradiation (DNR/VCR/PSL plus medium-dose VP/CY/TBI). Four patients in relapse or induction failure of B-precursor ALL without other complications underwent allogeneic HSCT. Initially, chemotherapy comprising DNR 60 mg/m2 for 3 days, VCR 1.4 mg/m2 for 1 day, and PSL 60 mg/m2 for 3 days was administered, which was followed by medium-dose VP/CY/TBI; some modifications were made for individual patients. All patients achieved engraftment and complete remission after HSCT. Regimen-related toxicities were tolerable and no patient died within 100 days. Two patients were alive without disease on days 563 and 1055. The third patient relapsed on day 951, while the fourth died on day 179 without disease. Our results indicate that intensified myeloablative HSCT should be considered for patients with refractory ALL.
著者
-
Asano Shigetaka
東京大学医科学研究所 血液腫瘍内科
-
Asano Shigetaka
Institute Of Medical Science University Of Tokyo
-
Kondo Takeshi
Stem Cell Transplantation Center Hokkaido University Hospital
-
Imamura M
Stem Cell Transplantation Center Hokkaido University Hospital
-
Arita Kotaro
Stem Cell Transplantation Center Hokkaido University Hospital
関連論文
- DOCK2 regulates cell proliferation through Rac and ERK activation in B cell lymphoma
- Clinical significance of minimal residual disease in adult acute lymphoblastic leukemia
- Abnormal expansion of naïve B lymphocytes after unrelated cord blood transplantation : a case report
- Complete remission of splenic marginal zone lymphoma after an acute flare-up of hepatitis B in a hepatitis B virus carrier
- TRIM24 mediates ligand-dependent activation of androgen receptor and is repressed by a bromodomain-containing protein, BRD7, in prostate cancer cells
- Bacterial Bloodstream Infection in Neutropenic Adult Patients after Myeloablative Cord Blood Transplantation : Experience of a Single Institution in Japan
- Pancreatic Hyperamylasemia and Hyperlipasemia in Association with Cytomegalovirus Infection following Unrelated Cord Blood Transplantation for Acute Myelogenous Leukemia
- Posttransplantation Engraftment and Safety of Cord Blood Transplantation with Grafts Containing Relatively Low Cell Doses in Adults
- Hemorrhagic Cystitis in Adults after Unrelated Cord Blood Transplantation : A Single-Institution Experience in Japan
- Varicella-Zoster Virus Encephalitis in a Patient Undergoing Unrelated Cord Blood Transplantation for Myelodysplastic Syndrome-Overt Leukemia
- Early-Onset Thyrotoxicosis after Unrelated Cord Blood Transplantation for Acute Myelogenous Leukemia
- Atypical Hypersensitivity to Mosquito Bites without Natural Killer Cell Proliferative Disease in an Adult Patient
- Unrelated Cord Blood Transplantation after Myeloablative Conditioning for Adult Patients with Refractory Anemia
- Human Herpesvirus 6 Variant B Infection in Adult Patients after Unrelated Cord Blood Transplantation
- Unrelated Cord Blood Transplantation with a Reduced-Intensity Conditioning Regimen following Autologous Transplantation for Multiple Myeloma
- Acute Myelogenous Leukemia M5b Developed during Clinical Remission of Castleman Disease
- Using Related Donors Other Than Genotypically HLA-Matched Siblings in Allogeneic Hematopoietic Stem Cell Transplantation for Hematologic Disease : A Single Institution Experience in Japan
- Severe Immune Dysfunction after Lethal Neutron Irradiation in a JCO Nuclear Facility Accident Victim
- Second Allogeneic Hematopoietic Stem Cell Transplantation for Leukemia Relapse After First Allogeneic Transplantation : Outcome of 16 Patients in a Single Institution
- Reduced-intensity unrelated donor bone marrow transplantation for hematologic malignancies
- Severe Autoimmune Thrombocytopenia After Allogeneic Bone Marrow Transplantation for Aplastic Anemia
- Incidence and Risk of Postherpetic Neuralgia after Varicella Zoster Virus Infection in Hematopoietic Cell Transplantation Recipients: Hokkaido Hematology Study Group
- Multicenter Prospective Study of Clonal Complications in Adult Aplastic Anemia Patients following Recombinant Human Granulocyte Colony-Stimulating Factor (Lenograstim) Administration
- Hematopoietic Capability of CD34^+ Cord Blood Cells: A Comparison With CD34^+ Adult Bone Marrow Cells
- Glycoprotein 130 and c-kit Signals Synergistically Induce Thrombopietin Production by Hematopoietic Cells
- Long-term Follow-up of Allogeneic Bone Marrow Transplantation after Reduced-Intensity Conditioning in Patients with Chronic Myelogenous Leukemia in the Chronic Phase
- Refractory Facial Cellulitis Following Cosmetic Rhinoplasty After Cord-blood Stem Cell Transplantation
- Preparative and Clinical Studies of Immunogene Therapy Using Autologous GM-CSF Transduced Tumor Vaccines for Stage IV Renal Cell Cancer
- CD4/CD8 double-positive adult T cell leukemia with preceding cytomegaloviral gastroenterocolitis
- Establishment of novel cell lines derived form two patients with chronic myelogenous leukemia in blast crisis; IMS-BC1 and IMS-BC2 which exhibit markedly different sensitivity to apoptosis
- Current Status of Hematopoietic Cell Transplantation for Adult Patients with Hematologic Diseases and Solid Tumors in Japan
- Advanced renal cell carcinoma treated with granulocytemacrophage colony-stimulating factor gene therapy : A clinical course of the first Japanese experience
- Graft-versus-tumor effect after reduced-intensity allogeneic hematopoietic stem cell transplantation in a patient with advanced colon cancer
- Usefulness of magnifying endoscopic evaluation of the terminal ileum for a patient with graft-versus-host disease after allogeneic hematopoietic stem cell transplantation
- Proliferation of CD4^+ Lymphocytes in a Patient With Chronic Graft-Versus-Host Disease After Allogeneic Bone Marrow Transplantation
- Successful treatment of acute myelogenous leukemia with favorable cytogenetics by reduced-intensity stem cell transplantation
- Regimen-Related Mucosal Injury of the Gut Increased the Incidence of CMV Disease after Allogeneic Bone Marrow Transplantation
- Hepatosplenic alpha/beta T cell lymphoma presenting with cold agglutinin disease.
- Hypogammaglobulinemia with a selective delayed recovery in memory B cells and an impaired isotype expression after rituximab administration as an adjuvant to autologous stem cell transplantation for non-Hodgkin lymphoma
- Autologous bone marrow transplantation for patients with advanced chronic myelogenous leukemia
- Differential effects of interleukin-12 and interleukin-15 on expansion of NK cell receptor-expressing CD8+ T cells
- Thrombotic microangiopathy after treatment with bortezomib and dexamethasone in a patient with multiple myeloma
- Ciprofloxacin inhibits lipopolysaccharide-induced toll-like receptor-4 and 8 expression on human monocytes derived from adult and cord blood
- Administration of micafungin as prophylactic antifungal therapy in patients undergoing allogeneic stem cell transplantation
- Acute-Onset Pancytopenia in a Postpartum Lactating Woman
- Synergistic up-regulation of Hexokinase-2, glucose transporters and angiogenic factors in pancreatic cancer cells by glucose deprivation and hypoxia
- Donor-Type Myelodysplastic Syndrome with t(2;3) and Monosomy 7 after Allogeneic Peripheral Blood Stem Cell Transplantation and Liver Transplantation in a Patient with Severe-Type Aplastic Anemia
- Effect of granulocyte colony-stimulating factor on IL-12 p40 production during chemotherapy for B-cell lineage non-Hodgkin's lymphoma patients
- Hypoxia suppresses the production of matrix metalloproteinases and migration of human monocyte-derived dendritic cells
- Adrenomedullin antagonist suppresses in vivo growth of human pancreatic cancer cells in SCID mice by suppressing angiogenesis
- Increased number of CD16(+)CD56(dim) NK cells in peripheral blood mononuclear cells after allogeneic cord blood transplantation
- HB Vaccination in the Prevention of Viral Reactivation in Allogeneic Hematopoietic Stem Cell Transplantation Recipients with Previous HBV Infection
- Efficacy and safety of Micafungin in Febrile NeutropenicPatients Treated for Hematological Malignancies
- Relationship between preexisting anti-varicella-zoster virus (VZV) antibody and clinical VZV reactivation in hematopoietic stem cell transplantation recipients.
- In vitro induction of resistance to metronidazole, and analysis of mutations in rdxA and frxA genes from Helicobacter pylori isolates
- Aleukemic leukemia cutis in a patient with Philadelphia chromosome-positive biphenotypic leukemia.
- HCV non-structural protein 3 and HCV RNA genome in non-Hodgkin lymphoma and transition of the serum HCV RNA level : a retrospective analysis in one institution
- A Case of Non-Hodgkin's Lymphoma and Invasive Thymoma Treated with R-CHOP Therapy
- Successful Reduced-intensity Stem Cell Transplantation (RIST) for a Patient with Malignant Lymphoma and an Ileostomy
- Potential Role of Natural Killer Cell Receptor-Expressing Cells in Immunotherapy for Leukemia
- Successful Micafungin (FK463) Treatment of Invasive Pulmonary Aspergillosis in a Patient with Acute Lymphoblastic Leukemia in a Phase II Study
- Rhabdomyolysis Caused by Distigmine Bromide
- Allogeneic Bone Marrow Transplantation as a Therapeutic Modality for Hematological Disorders : A Report Based on 39 Cases
- Pharmacokinetic studies of intravenous glycosylated recombinant human granulocyte colony-stimulating factor in various hematological disorders: inverse correlation between the half-life and bone marrow myeloid cell pool
- Donor cell leukemia after umbilical cord blood transplantation : recurrent or de novo? The importance of diagnosis for therapeutic decision making
- Hemophagocytosis as a para-neoplastic syndrome in NK cell leukemia
- ZAPS is a potent stimulator of signaling mediated by the RNA helicase RIG-I during antiviral responses
- The role of accessory cells in allogeneic peripheral blood stem cell transplantation
- A Novel FRET-Based Biosensor for the Measurement of BCR-ABL Activity and Its Response to Drugs in Living Cells
- Clinical significance of minimal residual disease in adult acute lymphoblastic leukemia
- Adrenomedullin antagonist suppresses tumor formation in renal cell carcinoma through inhibitory effects on tumor endothelial cells and endothelial progenitor mobilization.
- Outcome of medium-dose VP-16/CY/TBI superior to CY/TBI as a conditioning regimen for allogeneic stem cell transplantation in adult patients with acute lymphoblastic leukemia
- Sequential chemotherapy and myeloablative allogeneic hematopoietic stem cell transplantation for refractory acute lymphoblastic leukemia
- Donor cell leukemia after umbilical cord blood transplantation : recurrent or de novo? The importance of diagnosis for therapeutic decision making
- Association analysis of the NOD2 gene with susceptibility to graft-versus-host disease in a Japanese population
- Use of mycophenolate mofetil in patients received allogeneic hematopoietic stem cell transplantation in Japan
- Sequential chemotherapy and myeloablative allogeneic hematopoietic stem cell transplantation for refractory acute lymphoblastic leukemia
- Expansion of CD4+CD25+ regulatory T cells from cord blood CD4+ cells using the common γ-chain cytokines (IL-2 and IL-15) and rapamycin
- Efficacy of folinic acid in preventing oral mucositis in allogeneic hematopoietic stem cell transplant patients receiving MTX as prophylaxis for GVHD
- Outcome of medium-dose VP-16/CY/TBI superior to CY/TBI as a conditioning regimen for allogeneic stem cell transplantation in adult patients with acute lymphoblastic leukemia
- A fatal case of cytomegalovirus ventriculoencephalitis in a mycosis fungoides patient who received multiple umbilical cord blood cell transplantations
- HBV reactivation in malignant lymphoma patients treated with rituximab and bendamustine
- Current status of hematopoietic stem cell transplantation for acute radiation syndromes